Danish pharmaceutical giant Novo Nordisk is gearing up to introduce its blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. In a strategic move to gain an advantage over Eli Lilly’s newly launched Mounjaro (tirzepatide), Novo Nordisk has presented data showcasing Wegovy’s cardiovascular benefits in Indian patients, according to recent regulatory filings.
Farewell to Bharat Kumar: Cinema Icon Manoj Kumar Passes Away at 87″
Veteran actor and filmmaker Manoj Kumar, affectionately known as 'Bharat Kumar' for his iconic patriotic films, passed away in Mumbai early Friday morning at the age of 87. Renowned for classics like...
Discussion about this post